DarioHealth (DRIO) Tops Q2 EPS by 108c

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of $0.58, $1.08 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $6.15 million versus the consensus estimate of $6.66 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• DarioHealth Corp. (DRIO) PT Lowered to $8 at TD Cowen
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c